 This study found that severe COVID-19 patients are at high risk of developing secondary fungal infections with aspergillus species and mucus SPP, being the most common types. Additionally, patients with drug-resistant infections have a higher mortality rate than those with non-drug-resistant infections. This highlights the importance of early diagnosis and tailored treatment strategies in order to reduce the severity of the disease and improve survival rates. This article was authored by Yulia Bogdan, Akash Redi Redi Redi, Adithya Nilluri, and others.